🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 28036F105
- Market Cap
- Small Cap
- IPO
- 3/26/2021 · $16.00/share
Business: Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need.
Company Contact
- CEO
- Kevin Koch
- CFO
- Michael Carruthers
- Headquarters
- 1715 38th St. Boulder, CO 80301
- Phone
- 720-262-7002
- Investor Relations
- Kevin Koch · 303-735-8573 · IR@edgewisetx.com